Milestone Pharmaceuticals Q3 EPS $(0.52) Up From $(20.16) YoY

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.52) per share. This is a 97.42 percent increase over losses of $(20.16) per share from the same period last year.

Benzinga · 11/13/2019 12:11

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.52) per share. This is a 97.42 percent increase over losses of $(20.16) per share from the same period last year.